Use of new antiretroviral drugs and classes in Bahia, Brazil: a real life experience on salvage therapy of AIDS patients

AUTOR(ES)

Brites, Carlos, Nóbrega, Isabella, Netto, Eduardo Martins

FONTE

Braz J Infect Dis

DATA DE PUBLICAÇÃO

2015-10

RESUMO

ABSTRACTAntiretroviral therapy has significantly evolved in the last decade, with an increasing number of new drugs and classes. Currently, even heavily experienced patients can be successfully treated with new regimens. In Brazil, the recent incorporation of some new antiretroviral drugs made it possible to suppress HIV plasma viremia in most treated patients, with significant benefits in terms of quality of life and survival. However, little has been published on outcomes of patients under new drugs-based regimens. We reviewed the safety and efficacy of antiretroviral regimens using recently introduced drugs in Bahia. Our results confirm that patients using darunavir, raltegravir, enfuvirtide, or etravirine presented with a high rate of virological suppression without significant adverse events, after one year of follow-up.

Documentos Relacionados

• Tuberculosis incidence among people living with HIV/AIDS with virological failure of antiretroviral therapy in Salvador, Bahia, Brazil
• Marine microalgae on the southern coast of Bahia, Brazil: composition and new records of phytoplankton species
• Bacterial meningitis in patients with sickle cell anemia in Salvador, Bahia, Brazil: a report on ten cases
• Evaluation of HIV/AIDS patients' knowledge on antiretroviral drugs
• Dyslipidemia in AIDS patients on highly active antiretroviral therapy